BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11884371)

  • 1. Lovastatin enhances ecto-5'-nucleotidase activity and cell surface expression in endothelial cells: implication of rho-family GTPases.
    Ledoux S; Laouari D; Essig M; Runembert I; Trugnan G; Michel JB; Friedlander G
    Circ Res; 2002 Mar; 90(4):420-7. PubMed ID: 11884371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia enhances Ecto-5'-Nucleotidase activity and cell surface expression in endothelial cells: role of membrane lipids.
    Ledoux S; Runembert I; Koumanov K; Michel JB; Trugnan G; Friedlander G
    Circ Res; 2003 May; 92(8):848-55. PubMed ID: 12663485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of COX-2 expression by statins in human aortic smooth muscle cells. Involvement of geranylgeranylated proteins.
    Degraeve F; Bolla M; Blaie S; Créminon C; Quéré I; Boquet P; Lévy-Toledano S; Bertoglio J; Habib A
    J Biol Chem; 2001 Dec; 276(50):46849-55. PubMed ID: 11591701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase.
    Laufs U; Liao JK
    J Biol Chem; 1998 Sep; 273(37):24266-71. PubMed ID: 9727051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins.
    Essig M; Nguyen G; Prié D; Escoubet B; Sraer JD; Friedlander G
    Circ Res; 1998 Oct; 83(7):683-90. PubMed ID: 9758637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins).
    Eberlein M; Heusinger-Ribeiro J; Goppelt-Struebe M
    Br J Pharmacol; 2001 Aug; 133(7):1172-80. PubMed ID: 11487529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathway.
    Zhong WB; Hsu SP; Ho PY; Liang YC; Chang TC; Lee WS
    Biochem Pharmacol; 2011 Dec; 82(11):1663-72. PubMed ID: 21907187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of ecto-5'-nucleotidase in human umbilical vein endothelial cells by lipopolysaccharide.
    Li RW; Man RY; Vanhoutte PM; Leung GP
    Am J Physiol Heart Circ Physiol; 2008 Sep; 295(3):H1177-H1181. PubMed ID: 18641267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of geranylgeranylation mediates the effects of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors on microglia.
    Bi X; Baudry M; Liu J; Yao Y; Fu L; Brucher F; Lynch G
    J Biol Chem; 2004 Nov; 279(46):48238-45. PubMed ID: 15364922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins reduce amyloid-beta production through inhibition of protein isoprenylation.
    Ostrowski SM; Wilkinson BL; Golde TE; Landreth G
    J Biol Chem; 2007 Sep; 282(37):26832-26844. PubMed ID: 17646164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury.
    Mason JC; Ahmed Z; Mankoff R; Lidington EA; Ahmad S; Bhatia V; Kinderlerer A; Randi AM; Haskard DO
    Circ Res; 2002 Oct; 91(8):696-703. PubMed ID: 12386146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lovastatin on Rho isoform expression, activity, and association with guanine nucleotide dissociation inhibitors.
    Turner SJ; Zhuang S; Zhang T; Boss GR; Pilz RB
    Biochem Pharmacol; 2008 Jan; 75(2):405-13. PubMed ID: 17920041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells.
    Xia Z; Tan MM; Wong WW; Dimitroulakos J; Minden MD; Penn LZ
    Leukemia; 2001 Sep; 15(9):1398-407. PubMed ID: 11516100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of inhibition of cholesterol synthetic pathway on the activation of Ras and MAP kinase in mesangial cells.
    Bassa BV; Roh DD; Vaziri ND; Kirschenbaum MA; Kamanna VS
    Biochim Biophys Acta; 1999 Mar; 1449(2):137-49. PubMed ID: 10082972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvastatin, an HMG-CoA reductase inhibitor, facilitate adenosine production in the rat hearts via activation of ecto-5'-nucleotidase.
    Obata T; Nakashima M
    Microvasc Res; 2016 Sep; 107():1-5. PubMed ID: 27102210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin down-regulation plays a crucial role in 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor-induced apoptosis in cancer.
    Kaneko R; Tsuji N; Asanuma K; Tanabe H; Kobayashi D; Watanabe N
    J Biol Chem; 2007 Jul; 282(27):19273-81. PubMed ID: 17472962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lovastatin inhibits thrombospondin-1-induced smooth muscle cell chemotaxis.
    Esemuede N; Lee T; Maier KG; Sumpio BE; Gahtan V
    J Surg Res; 2011 Jun; 168(1):149-54. PubMed ID: 20338582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lovastatin blocks basic fibroblast growth factor-induced mitogen-activated protein kinase signaling in coronary smooth muscle cells via phosphatase inhibition.
    Skaletz-Rorowski A; Müller JG; Kroke A; Waltenberger J; Pulawski E; Pinkernell K; Breithardt G
    Eur J Cell Biol; 2001 Mar; 80(3):207-12. PubMed ID: 11322384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lovastatin modulates in vivo and in vitro the plasminogen activator/plasmin system of rat proximal tubular cells: role of geranylgeranylation and Rho proteins.
    Essig M; Vrtovsnik F; Nguyen G; Sraer JD; Friedlander G
    J Am Soc Nephrol; 1998 Aug; 9(8):1377-88. PubMed ID: 9697659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas.
    Dimitroulakos J; Marhin WH; Tokunaga J; Irish J; Gullane P; Penn LZ; Kamel-Reid S
    Neoplasia; 2002; 4(4):337-46. PubMed ID: 12082550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.